Stocks
CONMED (CNMD) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 179.3 | 7.80 | 192.5 | 272.2 | 193.5 | 211.4 | ||
| Changes by years, y/y, % | +58% | -96% | +2 368% | +41% | -29% | +11.2% | |||
CONMED. EBITDA US GAAP, bln rub
CONMED. EBITDA US GAAP, changes, %
CONMED. EBITDA US GAAP, sum by quarters, bln rub
CONMED (CNMD) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 24.4 | 54.9 | 32.5 | 85.7 | 38.3 | 211.4 | |
| Changes by years, y/y, % | -54% | -15% | -61% | +22% | +57% | |||
| Changes by quarters, q/q, % | -65% | +125% | -41% | +164% | -55% | |||
